OrthoSpineNews

APRIL 16, 2025

PsiFGuard project co-developed with US company Omnia Medical During 2024, SpineGuard finalized the design and industrialization of its new “PsiFGuard” product intended for posterior sacroiliac joint fusion (“PSIF”). DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D.,

X-ray 52

X-ray Scoliosis Joints Prevention 52

OrthoSpineNews

APRIL 10, 2025

PsiFGuard is now part of Omnia Medicals comprehensive product offering for ambulatory sacro-iliac joint fusion procedures, a fast growing segment. The latter was cleared by the FDA in September 2024 then officially launched at the end of January 2025 at the NANS (North American Neuromodulation Society) convention in Orlando. OmniaMedical.com.

Scoliosis 52

Scoliosis Spine Joints Clients 52

OrthoSpineNews

FEBRUARY 10, 2025

PsiFGuard is part of an innovative solution combining our technologies into an integrated kit matching perfectly the practical needs of healthcare providers offering ambulatory sacro-iliac joint fusion procedures to patients. The convention was well attended, and many physicians are eager to be trained on our procedure with this technology.

Joints 52

Joints Scoliosis Clinic Spine 52

OrthoSpineNews

JANUARY 7, 2025

It confirms that PsiFGuard greatly facilitates the placement of Omnias implant into the optimal position for success within the sacroiliac joint. The sacroiliac fusion market More than 15% of patients suffering from back pain are estimated to have a degenerative sacroiliac joint causing debilitating pain. Ciaran Bolger, M.D.,

X-ray 52

X-ray Joints Scoliosis Spine 52